In support of S.2355/H.R.5582 Patients Deserve Price Tags Act, in support of health care price transparency; Generic Drug User Fee Amendments (GDUFA); Prescription Drug User Fee Act (PDUFA)
2026 · 1st Quarter (Jan 1 - Mar 31)
U.S. PUBLIC INTEREST RESEARCH GROUP
Filed by U.S. PUBLIC INTEREST RESEARCH GROUP.
Open official filingSource-reported fields
Filing overview
- Type
- 1st Quarter - Report
- Posted
- Apr 17, 2026
- Income
- Not reported
- Expenses
- $10,000.00
- Registrant
- U.S. PUBLIC INTEREST RESEARCH GROUP
- Filing UUID
- 1242dd7f-b12f-44c4-abd5-4d0d1b7dcd26
- Termination date
- Not reported
Expense method: A
Literal source text
Lobbying issues and bill citations
Support for the Close the Shadow Banking Loophole Act, which would close an exemption that is being used by commercial, retail, and tech businesses to get the benefits of being an FDIC-backed bank without federal requirements.
Support for the Credit Card Competition Act in the House and Senate, to foster competition in the credit card processing marketplace. Calling on Congress to restore full funding for the CFPB.
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.